Screener
NeoGenomics NEO Cash Flow Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| -$7.55M+72.2% | $2.24M+105% | -$17.11M+34.0% | -$9.88M+35.5% | -$27.13M-53.3% | ||
| $8.56M-2.8% | $8.58M-6.2% | $8.78M-6.3% | $8.76M-10.8% | $8.8M-8.5% | ||
| $8.84M-14.3% | $8.22M-32.7% | $9.64M-10.4% | $8.04M-3.4% | $10.31M— | ||
| —— | $19.96M-1.8% | -$8.14M+67.9% | $1.34M-86.3% | $8.88M— | ||
| $11.77M+41.6% | $8.22M+30.0% | $5M+11.1% | $7.87M-32.1% | $8.31M-23.0% | ||
| $0-100% | —— | —— | —— | $463K— | ||
| -$11.85M-4,177% | -$8.32M+10.7% | -$5M-240% | -$6.31M— | -$277K— | ||
| $867K— | —— | —— | —— | —— | ||
| —— | —— | —— | $50.31M— | $50.31M— | ||
| $14.48M— | -$12.24M+94.0% | -$338K-136% | —— | —— | ||
| -$6.26M— | -$604K+99.7% | -$13.48M+35.3% | -$4.5M-190% | $0-100% | ||
| -$20.66M— | —— | -$13.14M+56.0% | -$6.53M-263% | —— |
FAQ
- Where does NeoGenomics's cash flow data come from?
- Every line is extracted from NeoGenomics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
